Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Synthesis of hollow Y zeolite for catalytic applications

Autor: Pagis, C., Bats, Nicolas, Dodin, M., Farrusseng, D., Tuel, A.

Publikováno v: 12th International Symposium on the "Scientific Bases for the Preparation of Heterogeneous Catalysts" (PREPA12)
12th International Symposium on the "Scientific Bases for the Preparation of Heterogeneous Catalysts" (PREPA12), Jul 2018, Louvain-La-Neuve Belgium
International Symposium on Zeolites and Microporous Crystals (ZMPC) 2018
International Symposium on Zeolites and Microporous Crystals (ZMPC) 2018, Aug 2018, Yokohama Japan

SSCI-VIDE+ING+CPG:DFA:ATU; International audience; Mainly motivated by catalytic applications, the design of zeolites with diverse and well controlled morphologies remains a topic of intense research and development. In this sense, it is worth highli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d64e088918e5bf4b698876a20c1f1c71
https://hal.archives-ouvertes.fr/hal-01832784

A "resistance calculator": Simple stewardship intervention for refining empiric practices of antimicrobials in acute-care hospitals.

Autor: Zilberman-Itskovich S; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Strul N; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Chedid K; University of Michigan School of Public Health, Ann Arbor, Michigan, United States., Martin ET; University of Michigan School of Public Health, Ann Arbor, Michigan, United States., Shorbaje A; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Vitkon-Barkay I; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Marcus G; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Michaeli L; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Broide M; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Yekutiel M; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Zohar Y; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Razin H; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Low A; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Strulovici A; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Israeli B; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Geva G; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Katz DE; Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel., Ben-Chetrit E; Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel., Dodin M; Shaare Zedek Medical Center, the Hebrew University Hadassah Medical School, Jerusalem, Israel., Dhar S; Detroit Medical Center, Detroit, Michigan, United States.; Wayne State University School of Medicine, Detroit, Michigan, United States., Parsons LM; Detroit Medical Center, Detroit, Michigan, United States.; Wayne State University School of Medicine, Detroit, Michigan, United States., Ramos-Mercado A; Detroit Medical Center, Detroit, Michigan, United States.; Wayne State University School of Medicine, Detroit, Michigan, United States., Kaye KS; University of Michigan Medical School, Ann Arbor, Michigan, United States., Marchaim D; Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2021 Sep; Vol. 42 (9), pp. 1082-1089. Date of Electronic Publication: 2021 Mar 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.

Autor: Ben-Chetrit E; Department of Infectious Diseases, Shaare Zedek Medical Center, affiliated with Hebrew University, Jerusalem, Israel., Eldaim MA; Division of Internal Medicine D, Shaare Zedek Medical Center, affiliated with Hebrew University, Jerusalem, Israel., Bar-Meir M; Department of Infectious Diseases, Shaare Zedek Medical Center, affiliated with Hebrew University, Jerusalem, Israel., Dodin M; Department of Hematology-Oncology, Shaare-Zedek Medical Center, affiliated with Hebrew University, Jerusalem, Israel., Katz DE; Division of Internal Medicine D, Shaare Zedek Medical Center, affiliated with Hebrew University, Jerusalem, Israel. Electronic address: dekatz1@gmail.com.

Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2019 Apr; Vol. 53 (4), pp. 423-428. Date of Electronic Publication: 2018 Dec 17.